Consistent with our observation in the therapeutic sensitivity analysis, high-NE-score cell lines from both SCLC and neuroblastoma were more sensitive to BCL2 depletion (Fig. 7D and E). This evidence concerns the gene BCL2 and small cell lung carcinoma.